ROBERT A. HAWKINS, M.D.; HENRY N. CLAMAN, M.D.; RICHARD A. F. CLARK, M.D.; JAMES C. STEIGERWALD, M.D.
Dermal collagen deposition is the hallmark of the early indurative phase of progressive systemic sclerosis (scleroderma). This process, however, tends to remit in late stages of the disease. Because mast cells are believed to participate in the development of fibrotic processes, we measured the density of the cutaneous mast cell population in clinically involved and uninvolved skin of a group of patients with scleroderma. Mast cell counts in clinically involved skin of patients with early stages of scleroderma (111 ±28 [SD] cells/mm2) were significantly greater than those in clinically uninvolved skin of the same patients (58 ±26 cells/mm2) and also greater than those of normal controls (50 ±14 cells/ mm2). Mast cell counts in clinically involved and uninvolved skin of patients with late scleroderma were normal. When mast cell density was analyzed by depth of dermis, an 85% increase was noted in involved papillary dermis and a 152% increase in involved reticular dermis in patients with early scleroderma when compared with densities in controls. These results suggest that mast cells may be important in the pathogenesis of the early cutaneous lesions of progressive systemic sclerosis, perhaps by promoting fibrosis.
Learn more about subscription options.
Register Now for a free account.
HAWKINS RA, CLAMAN HN, CLARK RAF, STEIGERWALD JC. Increased Dermal Mast Cell Populations in Progressive Systemic Sclerosis: A Link in Chronic Fibrosis?. Ann Intern Med. 1985;102:182–186. doi: 10.7326/0003-4819-102-2-182
Download citation file:
Published: Ann Intern Med. 1985;102(2):182-186.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only